• 1. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorophenoxyacetates
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenoxyacetic acid derivatives Chlorophenoxyacetates

Recent Advances in the Study of 2-(4-Chloro-2-cyclohexylphenoxy)acetic Acid (CAS: 19774-97-1)

The compound 2-(4-Chloro-2-cyclohexylphenoxy)acetic acid (CAS: 19774-97-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features, has shown promising potential in various therapeutic applications. Recent studies have focused on elucidating its mechanism of action, optimizing its synthesis, and exploring its pharmacological properties. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its significance in drug development and chemical biology.

One of the key areas of investigation has been the synthesis and structural modification of 2-(4-Chloro-2-cyclohexylphenoxy)acetic acid. Researchers have developed novel synthetic routes to improve yield and purity, which are critical for its application in drug discovery. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound and its derivatives. These efforts have led to the identification of more efficient and scalable synthesis methods, facilitating further research and potential commercialization.

In addition to synthetic advancements, recent studies have explored the biological activity of 2-(4-Chloro-2-cyclohexylphenoxy)acetic acid. Preliminary findings suggest that this compound exhibits notable anti-inflammatory and analgesic properties, making it a candidate for the development of new therapeutics for chronic pain and inflammatory diseases. Mechanistic studies have indicated that the compound may modulate key signaling pathways involved in inflammation, such as the NF-κB pathway. These insights provide a foundation for future research aimed at optimizing its pharmacological profile and minimizing potential side effects.

Another promising avenue of research involves the potential application of 2-(4-Chloro-2-cyclohexylphenoxy)acetic acid in oncology. Recent in vitro and in vivo studies have demonstrated its ability to inhibit the proliferation of certain cancer cell lines, particularly those associated with solid tumors. The compound's ability to induce apoptosis and suppress angiogenesis has been a focal point of these investigations. While these findings are preliminary, they underscore the compound's potential as a lead molecule for anticancer drug development.

Despite these encouraging results, challenges remain in the development of 2-(4-Chloro-2-cyclohexylphenoxy)acetic acid as a therapeutic agent. Issues such as bioavailability, metabolic stability, and toxicity profiles need to be addressed through further preclinical and clinical studies. Collaborative efforts between academic institutions and pharmaceutical companies will be essential to overcome these hurdles and translate the compound's potential into viable treatments.

In conclusion, 2-(4-Chloro-2-cyclohexylphenoxy)acetic acid (CAS: 19774-97-1) represents a promising candidate for drug development, with applications spanning anti-inflammatory, analgesic, and anticancer therapies. Continued research into its synthesis, mechanism of action, and pharmacological properties will be crucial for unlocking its full therapeutic potential. This research brief highlights the importance of interdisciplinary collaboration and innovative approaches in advancing the field of chemical biology and pharmaceutical sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)